EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data

Guangcai Mao, Shu Yang iD, Xiaofei Wang iD

Biometrics · 2025

DOI: 10.1093/biomtc/ujaf131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, 2025. Verfasst von Guangcai Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, United States. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FDA HHS, NIH HHS, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heterogeneous treatment effect plays a crucial role in precision medicine. There is evidence that real-world data, even subject to biases, can be employed as supplementary evidence for randomized clinical trials to improve the statistical efficiency of the heterogeneous treatment effect estimation. In this paper, for survival data with right censoring, we consider estimating the heterogeneous treatment effect, defined as the difference of the treatment-specific conditional restricted mean survival times given covariates, by synthesizing evidence from randomized clinical trials and the real-world data with possible biases. We define an omnibus bias function to characterize the effect of biases caused by unmeasured confounders, censoring, and outcome heterogeneity, and further, identify it by combining the trial and real-world data. We propose a penalized sieve method to estimate the heterogeneous treatment effect and the bias function. We further study the theoretical properties of the proposed integrative estimators based on the theory of reproducing kernel Hilbert space and empirical process. The proposed methodology outperforms the approach solely based on the trial data through simulation studies and an integrative analysis of the data from a randomized trial and a real-world registry on early-stage non-small-cell lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicModels, StatisticalHumansComputer SimulationData Interpretation, StatisticalBiasSurvival AnalysisLung NeoplasmsTreatment OutcomeCarcinoma, Non-Small-Cell LungBiometryTreatment Effect Heterogeneity

Stichwörter der Autor:innen

heterogeneous treatment effectinverse probability weightingnonparametric penalized estimationsieve approximationtime-to-event endpoint

Autor:innen und Institutionen

  • Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, United States.
  • Department of Statistics, North Carolina State University, Raleigh, NC 27695, United States.

ORCID-Profile: Shu Yang, Xiaofei Wang

Förderung

  • FDA HHS
  • NIH HHS
  • U.S. Department of Health and Human Services
  • Food and Drug Administration
  • National Institutes of Health

Zitieren

APA

Mao, G., Yang, S., & Wang, X. (2025). Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data. Biometrics. https://doi.org/10.1093/biomtc/ujaf131

Vancouver

Mao G, Yang S, Wang X. Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data. Biometrics. 2025. doi:10.1093/biomtc/ujaf131

BibTeX
@article{Mao2025,
  author = {Mao, Guangcai and Yang, Shu and Wang, Xiaofei},
  title = {Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data},
  journal = {Biometrics},
  year = {2025},
  doi = {10.1093/biomtc/ujaf131}
}
Kostenlos starten →